Physician profile
Thomas A Straub
NPI 1548696206
$2,152.86
in general payments reported to CMS, 2019-2025
19 companies · $523 in 2025
The $523 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $290 · 2022: $233 · 2023: $409 · 2024: $697 · 2025: $523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,629.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $397.21 | 2023-2024 | Ha Minuteman G3-R |
| Nalu Medical, INC. | $314.18 | 2025 | Nalu Neurostimulation System |
| Pfizer INC. | $217.94 | 2021-2025 | |
| Boston Scientific Corporation | $206.38 | 2023-2024 | Artisan, Wavewriter Alpha Prime 16 |
| Abbvie INC. | $204.08 | 2021-2024 | |
| Collegium Pharmaceutical, INC. | $193.01 | 2021-2024 | Xtampza, Belbuca |
| Globus Medical, INC. | $157.80 | 2025 | Omnia |
| Curonix LLC | $147.46 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $85.47 | 2022-2024 | Relistor |
| Antares Pharma, INC. | $44.73 | 2022-2024 | Xyosted |
| Amgen INC. | $37.38 | 2022 | |
| Halozyme INC | $27.22 | 2023 | |
| Eisai INC. | $25.51 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $17.47 | 2025 | |
| Relievant Medsystems, INC. | $17.29 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $16.68 | 2023 | Tirosint, Licart |
| Biohaven Pharmaceutical Holding Company LTD. | $15.14 | 2022 | |
| Merck Sharp & Dohme LLC | $14.49 | 2022 | |
| Bioventus LLC | $13.42 | 2024 | Supartz Fx Sodium Hyaluronate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Straub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.